These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1726788)

  • 1. Molecular methods for predicting the metastatic potential of prostate cancer.
    Schalken JA
    Cancer Surv; 1991; 11():43-54. PubMed ID: 1726788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers and determinants of prostate cancer metastasis.
    Gopalkrishnan RV; Kang DC; Fisher PB
    J Cell Physiol; 2001 Dec; 189(3):245-56. PubMed ID: 11748582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray.
    Bull JH; Ellison G; Patel A; Muir G; Walker M; Underwood M; Khan F; Paskins L
    Br J Cancer; 2001 Jun; 84(11):1512-9. PubMed ID: 11384102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IPM-FISH, a new M-FISH approach using IRS-PCR painting probes: application to the analysis of seven human prostate cell lines.
    Aurich-Costa J; Vannier A; Grégoire E; Nowak F; Cherif D
    Genes Chromosomes Cancer; 2001 Feb; 30(2):143-60. PubMed ID: 11135431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer metastasis-suppressor genes: a current perspective.
    Yoshida BA; Chekmareva MA; Wharam JF; Kadkhodaian M; Stadler WM; Boyer A; Watabe K; Nelson JB; Rinker-Schaeffer CW
    In Vivo; 1998; 12(1):49-58. PubMed ID: 9575426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
    Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
    Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers associated with prostate cancer progression.
    Zhau HE; Pisters LL; Hall MC; Zhao LS; Troncoso P; Pollack A; Chung LW
    J Cell Biochem Suppl; 1994; 19():208-16. PubMed ID: 7529853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
    Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
    J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
    Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.